Hearing Loss Trial, Recruiting (NCT06490237)

Hearing Loss Trial, Recruiting NCT06490237 Sponsor: CHU de Reims Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT06490237 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are male or female and aged 18 or over
You are scheduled to have surgery in a specific area at the base of the brain called the cerebellopontine angle (this includes procedures such as microvascular decompression, vestibular neurotomy, or removal of a meningioma or schwannoma tumour)
You either have a mild to severe level of hearing loss in the ear being operated on (as measured by a specific hearing test), OR you have normal hearing in the ear being operated on (as measured by the same type of test)
You are covered by a social security (health insurance) system
You have read the study information and agreed in writing to take part by signing a consent form

Who may not be able to join:

Your auditory (hearing) nerve cannot be accessed during surgery because the tumour has completely grown into it (confirm with trial site)
Your auditory nerve cannot be accessed during surgery because of an unexpected feature of your anatomy that was not spotted before the operation, making it impossible to record from the nerve (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03.26.78.68.92

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06490237

Sponsor: CHU de Reims

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: 03.26.78.68.92

More information: https://clinicaltrials.gov/study/NCT06490237

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are male or female and aged 18 or over
You are scheduled to have surgery in a specific area at the base of the brain called the cerebellopontine angle (this includes procedures such as microvascular decompression, vestibular neurotomy, or removal of a meningioma or schwannoma tumour)
You either have a mild to severe level of hearing loss in the ear being operated on (as measured by a specific hearing test), OR you have normal hearing in the ear being operated on (as measured by the same type of test)
You are covered by a social security (health insurance) system
You have read the study information and agreed in writing to take part by signing a consent form

Who may not be able to join:

Your auditory (hearing) nerve cannot be accessed during surgery because the tumour has completely grown into it (confirm with trial site)
Your auditory nerve cannot be accessed during surgery because of an unexpected feature of your anatomy that was not spotted before the operation, making it impossible to record from the nerve (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

CHU de Reims

Registry

ClinicalTrials.gov

Start date

7 December 2021

Est. completion

7 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Compare the amplitude of global evoked auditory nerve activity; Compare the spectrum of global evoked auditory nerve activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov